Tirzepatide 100mg (10 Vials / Kit)

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This dual mechanism of action represents a new approach in metabolic research, targeting two incretin pathways simultaneously.

Research has shown that Tirzepatide demonstrates potent effects on glycemic control, appetite suppression, and body weight reduction in preclinical models. Its unique pharmacology offers researchers a tool to study the synergistic effects of combined incretin receptor activation on metabolic pathways.

For research use only. Not for human consumption. This product is intended solely for in vitro research and laboratory use.